Pfizer Buying Cupertino-Based NextWave Pharmaceuticals For Up To $700M
Pfizer said it will buy NextWave Pharmaceuticals Inc., a company that makes a liquid attention deficit hyperactivity disorder drug, in a deal worth as much as $700 million.
Watch CBS News
Pfizer said it will buy NextWave Pharmaceuticals Inc., a company that makes a liquid attention deficit hyperactivity disorder drug, in a deal worth as much as $700 million.
It happens across the country including here in the Bay Area, doctors cashing in on checks from pharmaceutical companies.
